EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The fibrinolysis renaissance

Nicola J Mutch, Robert L Medcalf

Journal of Thrombosis and Haemostasis · 2023

DOI: 10.1016/j.jtha.2023.09.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023. Verfasst von Nicola J Mutch und 1 weiteren Autor:innen. Beteiligte Einrichtung: Aberdeen Cardiovascular & Diabetes Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen,…. Hauptthemen laut MEDLINE: Fibrinolysis, Fibrinolysin. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Medical Research Scotland, Heart Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrinolysis is the system primarily responsible for removal of fibrin deposits and blood clots in the vasculature. The terminal enzyme in the pathway, plasmin, is formed from its circulating precursor, plasminogen. Fibrin is by far the most legendary substrate, but plasmin is notoriously prolific and is known to cleave many other proteins and participate in the activation of other proteolytic systems. Fibrinolysis is often overshadowed by the coagulation system and viewed as a simplistic poorer relation. However, the primordial plasminogen activators evolved alongside the complement system, approximately 70 million years before coagulation saw the light of day. It is highly likely that the plasminogen activation system evolved with its roots in primordial immunity. Almost all immune cells harbor at least one of a dozen plasminogen receptors that allow plasmin formation on the cell surface that in turn modulates immune cell behavior. Similarly, numerous pathogens express their own plasminogen activators or contain surface proteins that provide binding sites for host plasminogen. The fibrinolytic system has been harnessed for clinical medicine for many decades with the development of thrombolytic drugs and antifibrinolytic agents. Our refined understanding and appreciation of the fibrinolytic system and its alliance with infection and immunity and beyond are paving the way for new developments and interest in novel therapeutics and applications. One must ponder as to whether the nomenclature of the system hampered our understanding, by focusing on fibrin, rather than the complex myriad of interactions and substrates of the plasminogen activation system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrinolysisFibrinolysinHumansPlasminogen ActivatorsPlasminogenFibrinSerine Proteases

Stichwörter der Autor:innen

PAI-1fibrinolysisplasminogenplasminogen activatorstranexamic acidα(2)-antiplasmin

Substanzen

FibrinolysinPlasminogen ActivatorsPlasminogenFibrinSerine Proteases

Autor:innen und Institutionen

  • Aberdeen Cardiovascular & Diabetes Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill, Aberdeen, UK. Electronic address: n.j.mutch@abdn.ac.uk.
  • Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Förderung

  • British Heart Foundation
  • Medical Research Scotland
  • Heart Research UK
  • NC3Rs
  • National Health and Medical Research Council

Zitieren

APA

Mutch, N. J., & Medcalf, R. L. (2023). The fibrinolysis renaissance. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.09.012

Vancouver

Mutch NJ, Medcalf RL. The fibrinolysis renaissance. Journal of Thrombosis and Haemostasis. 2023. doi:10.1016/j.jtha.2023.09.012

BibTeX
@article{Mutch2023,
  author = {Mutch, Nicola J and Medcalf, Robert L},
  title = {The fibrinolysis renaissance},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2023},
  doi = {10.1016/j.jtha.2023.09.012}
}
Kostenlos starten →